ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted - ProAxsis

Our website is currently being updated and you may experience some limited functionality at this time.

ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted

WP_Developer

November 11, 2022

Recent Posts

American Thoracic Society Annual Meeting Washington DC, 19-24 May 2023

November 11, 2022

Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023

November 11, 2022

Texas Lung Cancer Conference Austin, TX 30March – 1April 2023

November 11, 2022

Have Any Questions?

Categories

November 11, 2022

Share This :